Re-visiting pH-adjusted potassium to avoid hypokalemic crisis during management of diabetic ketoacidosis: A conceptual framework

Diabetes Metab Syndr. 2021 Mar-Apr;15(2):573-580. doi: 10.1016/j.dsx.2021.03.001. Epub 2021 Mar 5.

Abstract

Background and aims: Diabetic ketoacidosis (DKA) treatment guidelines recommend to initiate potassium-replacement when serum potassium (SK) drops within normal range, and to withhold insulin if SK is below normal. Despite strict recommendations, hypokalemia is frequently observed in DKA.

Methods: Scientific literature was thoroughly searched to find 1) DKA treatment guidelines, 2) studies reporting hypokalemia in DKA, 3) and literature elaborating mechanisms involved in hypokalemia.

Results: Acidosis affects SK and its regulators including insulin, catecholamines and aldosterone. Current conceptual framework is an argument to gauge the degree of hypokalemia before it strikes DKA patients utilizing SK level after adjusting it with pH. Suggested approach will reduce hypokalemia risk and its associated complications. The nomogram calculates pH-adjusted potassium and expected potassium loss. It also ranks hypokalemia associated risk, and proposes the potassium-replacement rate over given time period. The differences between current DKA treatment guidelines and proposed strategy are also discussed. Moreover, reasons and risk of hyperkalemia due to early initiation of potassium replacement and remedial actions are debated.

Conclusion: In light of proposed strategy, utilizing the nomogram ensures reduced incidence of hypokalemia in DKA resulting in improved clinical and patient outcomes. Pharmacoeconomic benefits can also be expected when avoiding hypokalemia ensures early discharge.

Keywords: Cardiovascular outcome; Diabetic ketoacidosis; Emergency department; Hypokalemia; Patient outcome; Potassium.

Publication types

  • Review

MeSH terms

  • Concept Formation
  • Diabetic Ketoacidosis / blood*
  • Diabetic Ketoacidosis / drug therapy
  • Diabetic Ketoacidosis / epidemiology
  • Disease Management*
  • Humans
  • Hydrogen-Ion Concentration
  • Hypoglycemic Agents / blood
  • Hypoglycemic Agents / therapeutic use
  • Hypokalemia / blood*
  • Hypokalemia / drug therapy
  • Hypokalemia / epidemiology
  • Nomograms*
  • Potassium / blood*
  • Potassium / therapeutic use
  • Practice Guidelines as Topic / standards

Substances

  • Hypoglycemic Agents
  • Potassium